Metabolic syndrome. Metabolic disorder, unspecified
Conditions
Interventions
Intervention 1: 500 mg soft gel Astashrymp oil that is produced by Canadian companies will be consumed for 8 weeks. Intervention 2: One soft gel containing corn oil will be consumed for 8 weeks.
Treatment - Drugs
Placebo
500 mg soft gel Astashrymp oil that is produced by Canadian companies will be consumed for 8 weeks.
One soft gel containing corn oil will be consumed for 8 weeks.
Sponsors
Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
10 Years to 18 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: the age range of 10-18; no special diet for at least 2 months; no taking of NSAIDS (Ibuprofen, Aspirin, Warfarin, etc.) and thyroid; drugs that reduce appetite and decrease fat and blood sugar; the use of hormone therapy, sedatives, antidepressants and anticoagulants. Exclusion criteria: lack of proper use of drugs or placebo; people who are allergic to fish and any seafood and fish oil; taking anticoagulants; people with hemophilia.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total antioxidant capacity. Timepoint: Before and after the intervention. Method of measurement: µmol/L.;Total cholesterol. Timepoint: Before and after the intervention. Method of measurement: mg/dl.;Low density lipoprotein-cholesterol. Timepoint: Before and after the intervention. Method of measurement: mg/dl.;High density lipoprotein-cholesterol. Timepoint: Before and after the intervention. Method of measurement: mg/dl.;Triglycerides. Timepoint: Before and after the intervention. Method of measurement: mg/dl.;Blood pressure. Timepoint: Before and after the intervention. Method of measurement: mmhg with sphygmomanometer.;Fasting blood sugar. Timepoint: Before and after the intervention. Method of measurement: mg/dl.;Insulin. Timepoint: Before and after the intervention. Method of measurement: µU/ml.;Interleukin 6. Timepoint: Before and after the intervention. Method of measurement: pg/ml.;Tumor necrosis factor-alpha. Timepoint: Before and after the intervention. Method of measurement: pg/ml.;High-sensitivity C-reactive protein. Timepoint: Before and after the intervention. Method of measurement: mg/dl.;Weight. Timepoint: Before and after the intervention. Method of measurement: Kg with scale.;Waist circumference. Timepoint: Before and after the intervention. Method of measurement: Cm. | — |
Secondary
| Measure | Time frame |
|---|---|
| Waist to hip ratio. Timepoint: before and after intervention. Method of measurement: Calculation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Motahar Heidari-Beni
Isfahan University of Medical Sciences
Outcome results
None listed